Alpha Tau Medical is now initiating its Alpha DaRT clinical trial at IRST, Italy. The great team at IRST and Prof. Yona Keisari as well as Amnon Gat are excited about this opportunity to study the efficacy of Alpha DaRT in cancer patients suffering from Squamous Cell Carcinoma (SCC) of the skin. The revolutionary radiotherapy treatment enables a highly potent and specific targeting of solid tumors. Clinical trials in Israel showed highly promising results and the team strives to help millions of patients around the world.
IRST (Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori) was founded in 2007 and is situated in Meldola, Italy. The Centre is known for its excellent cancer management and research. With specification in Medical Oncology, Nuclear Medicine, Radio-Metabolic and Immunotherapy as well as Radiotherapy, IRST enables a wide range of personalized diagnostic-therapeutic programs to be offered to patients.